Potential conflict of interest: Nothing to report.
Liver Failure/Cirrhosis/Portal Hypertension
Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control study
Article first published online: 15 OCT 2013
© 2013 by the American Association for the Study of Liver Diseases
Volume 58, Issue 6, pages 2079–2088, December 2013
How to Cite
Ripoll, C., Genescà, J., Araujo, I. K., Graupera, I., Augustin, S., Tejedor, M., Cirera, I., Aracil, C., Sala, M., Hernandez-Guerra, M., Llop, E., Escorsell, A., Catalina, M. V., Cañete, N., Albillos, A., Villanueva, C., Abraldes, J. G., Bañares, R. and Bosch, J. (2013), Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control study. Hepatology, 58: 2079–2088. doi: 10.1002/hep.26629
- Issue published online: 26 NOV 2013
- Article first published online: 15 OCT 2013
- Accepted manuscript online: 31 JUL 2013 08:43AM EST
- Manuscript Accepted: 26 JUN 2013
- Manuscript Revised: 29 MAY 2013
- Manuscript Received: 15 MAR 2013
Additional Supporting Information may be found in the online version of this article.
|hep26629-sup-0001-suppfig1.tif||197K||Supplementary Figure 1: Survival curves of patients after variceal bleeding with hepatocellular carcinoma according to BCLC stage (curves identified on the graph) compared to patients without hepatocellular carcinoma (continuous line). Breslow test p< 0.001|
|hep26629-sup-0002-supptable1.doc||57K||Suplementary Table 1. Comparison of BCLC C and D with and without secondary Prophylaxis|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.